Teacher Retirement System of Texas lessened its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 13.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,185 shares of the company's stock after selling 7,243 shares during the period. Teacher Retirement System of Texas' holdings in Encompass Health were worth $4,265,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after purchasing an additional 137 shares during the period. Avior Wealth Management LLC bought a new position in Encompass Health in the 3rd quarter valued at about $40,000. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the period. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the 4th quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. Institutional investors own 97.25% of the company's stock.
Analyst Upgrades and Downgrades
EHC has been the subject of several research reports. KeyCorp increased their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays lifted their price target on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Ten analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $107.67.
View Our Latest Stock Report on EHC
Insider Buying and Selling at Encompass Health
In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 2.10% of the company's stock.
Encompass Health Trading Down 0.4 %
Shares of NYSE:EHC traded down $0.39 during trading on Friday, reaching $100.75. The stock had a trading volume of 457,600 shares, compared to its average volume of 654,706. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $104.55. The firm's fifty day moving average is $98.55 and its 200 day moving average is $97.31. The stock has a market cap of $10.15 billion, a price-to-earnings ratio of 22.59, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.
Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.
Encompass Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is presently 15.25%.
About Encompass Health
(
Free Report)
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading

Before you consider Encompass Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.
While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.